The Effect of Cooperative Care in the Treatment of
Head and Neck Cancer: Evaluating
Perceptions of Self-CareAbility, 2001
Demographic and Psychosocial Profile of Patients
Attending Free, Community Head and Neck Cancer Screening Clinics, 2001
A Randomized, Investigator-Masked, Multicenter
Study to Compare the Safety and Efficacy of Nystatin Oral Suspension and
Nystatin Frozen Oral Suspension (“Popsicle”) in the Treatment of Patients
with Oral Candidiasis.”
Evaluation of the Patency of the Internal Jugular
Vein in Patients Treated for Head and Neck Cancer.
Secondary Investigator: A Phase III, Multicenter,
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and
Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and
Neck Region, 2001, $48,800.
Co-Principal Investigator: A Phase II Activity and
Safety Study of IntraDose (Cisplatin/Epinephrine Injectable Gel) when Given in
Combination with Systemic Chemotherapy, Paclitaxel and Carboplatin in the
Treatment of patients with Squamous Cell Carcinoma of the Head and Neck, 2001,
$42,501.
Principal Investigator: A Phase IIA Study of the
Efficacy and Tolerability of J-107088 in Patients with Advanced Squamous Cell
Carcinomas of the Head and Neck, 2000, $12,872.
Co-Recipient:
Coping with Head and Neck Cancer: A Guide for Patients and Families,
funded by Pfizer Mini-Medical School Grant, November 1999, $10,000
Principal Investigator:
The effects of chitosan on extraction wound healing in rats, Hoechst-Roussell
Pharmaceutical Grant, #17
238-38201 $1,539.32
Principal Investigator:
The effects of chitosan on extraction wound healing in rats, Hoechst-Roussell
Pharmaceutical Grant, #85 238 38201 $1,631.00
Principal Investigator:
The effects of immobilization of the rabbit temporomandibular joint,
Research funded by Department of Surgery, University of Nebraska Medical
Center
Principal
Investigator: The effects of new
hemostatic, chitosan, on extraction wound healing in rabbits, Research Project
#86-20, Funded by College of Dentistry Research Grant, $456.00
Co-Recipient:
Coping with Head and Neck Cancer: A Guide for Patients and Families, funded by
Pfizer Mini-Medical School Grant, November 1999, $10,000
Principal
Investigator: The effects of chitosan on extraction wound healing in rats,
Hoechst-Roussell Pharmaceutical Grant, #17 238-38201 $1,539.32
Principal
Investigator: The effects of chitosan on extraction wound healing in rats,
Hoechst-Roussell Pharmaceutical Grant, #85 238 38201 $1,631.00
Principal
Investigator: The effects of immobilization of the rabbit temporomandibular
joint, Research funded by Department of Surgery, University of Nebraska
Medical Center
Principal
Investigator: The effects of new hemostatic, chitosan, on extraction wound
healing in rabbits, Research Project #86-20, Funded by College of Dentistry
Research Grant, $456.00
Principal
Investigator: Metastatic neck disease: evaluation by nuclear magnetic
resonance, Internal write-off support, Clinical Research Unit Subcommittee,
#52-842-249 61, $206.15/MRI exam
Co-Principal
Investigator: MAB-9510 Phase I-II Study of Radioimmunoconjugate 111 In Li Lo -
16. 88: in Head and Neck Squamous Cell Cancer, BB-IND 6310, $80,430.00
Co-Principal
Investigator: MGA/09-054-191 9p21, 3p21 in Premalignant Lesions of the Oral
Cavity and Oropharynx, College of Dentistry Research Seed Grant, November
1996-June 1997, $6000
Co-Principal
Investigator: MAB-9706 A Clinical Evaluation of the Preliminary Safety and and
Feasibility of Radioimmunotherapy using LiLo-16.88, a Human Monoclonal
Antibody Conjugate administered by Direct Intratumoral Injection in Patients
with Head and Neck Squamous Cell Carcinoma, IRB 448-97, $64,000
Co-Principal
Investigtor MAB 9806-01.A. Phase I, II Multicenter Dose Escalation Study of
Radioimmunotherapy using Indium in III and Yttrium Y90 Labeled LiLo-16.88, a
Human Monoclonal Antibody Conjugate Administered by Direct Intratumoral
Injection in Patients with Recurrent Head and Neck Squamous Cell Cancer.
Co-Principal
Investigator-A Phase I/II Dose Escalation Study of Radioimmunotherapy Using in
111 and Yttrium Y 90 labeled LiLo-16.88, a Human Monoclonal Antibody Conjugate
Administered by Direct Intratumoral Injection in Patients with Recurrent Head
and Neck Squamous Cell Cancer-MAB 9806-01-May, 1999, $100,000
Co-Principal
Investigator-A Phase I, Pharmacokinetic Study of 9 mg and 30 mg IB-367
Comparing Antimicrobial Activity in Patients Who are Undergoing Radiation
Therapy with or without Concurrent Chemotherapy for Head and Neck
Carcinoma-PG-010-August, 1999, $18,125.
Co-Investigator:
The application of computer aided cytology (Oral CDXTM) for detection of
precancerous and cancerous lesions of the oral mucosa: A multicenter
prospective clinical trial. Oral Scan TM Laboratories, Inc. IRB #236-98,
$100.00/patient.
Co-Investigator:
Randomized Trial Using Aspirin for Premalignant Lesions of the Head and Neck,
funded by Nebraska Methodist Hospital Foundation, July 1996, $10,000
Co-Investigator: Randomized Trial Using Aspirin
for Premalignant Lesions, funded by American Cancer Society IRG-165h, January
1997-January 1998, $11,750
Back to Top
Lydiatt DD, Murayama KM, Hollins RR, Thompson JS:
Laparoscopic Gastrostomy vs Open Gastrostomy for Head and Neck Cancer
Patients. Laryngoscope, 1996 March, 106(3): 1-4.
Johnson PJ, Lydiatt DD, Hollins RR and Rydlund
KW. Malignant Nerve Sheath Tumor of the Nasal Septum. Otolaryngology
Head and Neck Surgery, 1996 July, 115(1): 132-134.
Cihak RA, Lydiatt WM, Lydiatt DD, Bridge JA:
Synovial Sarcoma of the Head and Neck: Chromosomal Translocation (X;18) as
a Diagnostic Tool. Head and Neck Surgery, 1997 September;
19:549-553.
.Lydiatt WM, Anderson PE, Bazzana T, Casale M, Hughes
CJ, Huvos AG, Lydiatt DD, Schantz SP: Molecular Support for Field
Cancerizations in the Head and Neck. Cancer, 1998 April, 82(7):
1376-1380.
Lydiatt DD, Lydiatt WM, Hollins RR, Friedman AC:
Free Fibula Options in the Patient with Failed Mandibular Reconstruction. Journal
of Maxillofacial Surgery, 1998; 56:444-446.
Johnson PJ; Huerter JV; Ogren FP, Imig CN; Lydiatt
DD: Chondrosarcoma of the Nasal Septum: A Case Report and Review of
the Literature. Ear, Nose and Throat Journal, accepted May 1998.
Weekly M, Lydiatt DD, Baker S, Lydiatt WM:
Primary Cutaneous Adenoid Cystic Carcinoma Metastatic to Cervical Lymph
Nodes. Head and Neck Surgery, accepted March 1998.
Johnson P, Lydiatt DD, Baxter J, Hollins R,
Lydiatt WM: Microvascular Reconstruction of the Head and Neck Cancer
Patient: A Team Approach, Association of Operating Room Nurses Journal,
accepted February 1999.
Lydiatt DD, Hollins RR, Friedman AC, Lydiatt CA:
The Team Concept in Mandibular Reconstruction after Ablative Oncologic
Surgery. Journal of Oral Maxillofacial Surgery, accepted August
1999.
Lydiatt DD, Lydiatt WM, Karrer FW, Grasz F: Tobacco
Litigation and Legislation. Head and Neck Surgery, accepted
December 1999.
Lydiatt DD, Hollins RR,
Friedman AC, Lydiatt CA: The Team Concept in Mandibular Reconstruction after
Ablative Oncologic Surgery. Journal
of Oral Maxillofacial Surgery, Cutaneous Adenoid Cystic Carcinoma
Metastatic to Cervical Lymph Nodes. Head
and Neck Surgery, 2000;
22:84-86.
2000 June, 58(6):607-10.
Lydiatt DD, Lydiatt WM,
Karrer FW, Grasz F: Tobacco Litigation and Legislation.
Head and Neck Surgery, 2000
October, 22(7):643-8.
Lydiatt DD: The Surgical
Approach to Organ Preservation in the Treatment of Cancer of the Larynx:
A Commentary. Oncology,
2001 June, 15(6):798-799.
Lydiatt
DD: Medical Malpractice and Cancer of the Larynx.
Laryngoscope, 2002
February, 112:1-4.
Back to Top